Literature DB >> 9144774

The role of divalent cations in structure and function of murine adenosine deaminase.

B F Cooper1, V Sideraki, D K Wilson, D Y Dominguez, S W Clark, F A Quiocho, F B Rudolph.   

Abstract

For murine adenosine deaminase, we have determined that a single zinc or cobalt cofactor bound in a high affinity site is required for catalytic function while metal ions bound at an additional site(s) inhibit the enzyme. A catalytically inactive apoenzyme of murine adenosine deaminase was produced by dialysis in the presence of specific zinc chelators in an acidic buffer. This represents the first production of the apoenzyme and demonstrates a rigorous method for removing the occult cofactor. Restoration to the holoenzyme is achieved with stoichiometric amounts of either Zn2+ or Co2+ yielding at least 95% of initial activity. Far UV CD and fluorescence spectra are the same for both the apo- and holoenzyme, providing evidence that removal of the cofactor does not alter secondary or tertiary structure. The substrate binding site remains functional as determined by similar quenching measured by tryptophan fluorescence of apo- or holoenzyme upon mixing with the transition state analog, deoxycoformycin. Excess levels of adenosine or N6- methyladenosine incubated with the apoenzyme prior to the addition of metal prevent restoration, suggesting that the cofactor adds through the substrate binding cleft. The cations Ca2+, Cd2+, Cr2+, Cu+, Cu2+, Mn2+, Fe2+, Fe3+, Pb2+, or Mg2+ did not restore adenosine deaminase activity to the apoenzyme. Mn2+, Cu2+, and Zn2+ were found to be competitive inhibitors of the holoenzyme with respect to substrate and Cd2+ and Co2+ were noncompetitive inhibitors. Weak inhibition (Ki > or = 1000 microM) was noted for Ca2+, Fe2+, and Fe3+.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144774      PMCID: PMC2143705          DOI: 10.1002/pro.5560060509

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  18 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Adenosine deaminase from Escherichia coli.

Authors:  P Nygaard
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

3.  Metal-free dialysis tubing.

Authors:  D S Auld
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

4.  Purification and characterization of adenosine deaminase from a genetically enriched mouse cell line.

Authors:  D E Ingolia; C Y Yeung; I F Orengo; M L Harrison; E G Frayne; F B Rudolph; R E Kellems
Journal:  J Biol Chem       Date:  1985-10-25       Impact factor: 5.157

5.  Adenosine deaminase from human erythrocytes.

Authors:  R P Agarwal; R E Parks
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

6.  Adenosine deaminase: solvent isotope and pH effects on the binding of transition-state and ground-state analogue inhibitors.

Authors:  L C Kurz; C Frieden
Journal:  Biochemistry       Date:  1983-01-18       Impact factor: 3.162

7.  Adenosine aminohydrolase. Binding and hydrolysis of 2-and 6-substituted purine ribonucleosides and 9-substituted adenine nucleosides.

Authors:  B M Chassy; R J Suhadolnik
Journal:  J Biol Chem       Date:  1967-08-25       Impact factor: 5.157

8.  Transition-state stabilization by adenosine deaminase: structural studies of its inhibitory complex with deoxycoformycin.

Authors:  L Frick; R Wolfenden; E Smal; D C Baker
Journal:  Biochemistry       Date:  1986-04-08       Impact factor: 3.162

9.  The characterization of an adenosine deaminase from chicken serum.

Authors:  A A Rokosu
Journal:  Comp Biochem Physiol B       Date:  1983

10.  Site-directed mutagenesis of active site glutamate-217 in mouse adenosine deaminase.

Authors:  K A Mohamedali; L C Kurz; F B Rudolph
Journal:  Biochemistry       Date:  1996-02-06       Impact factor: 3.162

View more
  8 in total

Review 1.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

2.  Metal ion dependence of recombinant Escherichia coli allantoinase.

Authors:  Scott B Mulrooney; Robert P Hausinger
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

3.  The role of Zn2+ on the structure and stability of murine adenosine deaminase.

Authors:  Weiling Niu; Qin Shu; Zhiwei Chen; Scott Mathews; Enrico Di Cera; Carl Frieden
Journal:  J Phys Chem B       Date:  2010-09-03       Impact factor: 2.991

4.  Identification of a new class of adenosine deaminase from Helicobacter pylori with homologs among diverse taxa.

Authors:  Erica F Miller; Robert J Maier
Journal:  J Bacteriol       Date:  2013-07-12       Impact factor: 3.490

5.  The bacterial meta-cleavage hydrolase LigY belongs to the amidohydrolase superfamily, not to the α/β-hydrolase superfamily.

Authors:  Eugene Kuatsjah; Anson C K Chan; Marek J Kobylarz; Michael E P Murphy; Lindsay D Eltis
Journal:  J Biol Chem       Date:  2017-09-20       Impact factor: 5.157

6.  Biochemical characterization of adenosine deaminase (CD26; EC 3.5.4.4) activity in human lymphocyte-rich peripheral blood mononuclear cells.

Authors:  L R Costa; A K Y de Souza; J N Scholl; F Figueiró; A M O Battastini; J A Dos Santos Jaques; F F Zanoelo
Journal:  Braz J Med Biol Res       Date:  2021-05-24       Impact factor: 2.590

7.  Modulatory effect of iron chelators on adenosine deaminase activity and gene expression in Trichomonas vaginalis.

Authors:  Muriel Primon-Barros; Graziela Vargas Rigo; Amanda Piccoli Frasson; Odelta dos Santos; Lisiane Smiderle; Silvana Almeida; Alexandre José Macedo; Tiana Tasca
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-10-23       Impact factor: 2.743

8.  Molecular Evidence of Adenosine Deaminase Linking Adenosine A2A Receptor and CD26 Proteins.

Authors:  Estefanía Moreno; Júlia Canet; Eduard Gracia; Carme Lluís; Josefa Mallol; Enric I Canela; Antoni Cortés; Vicent Casadó
Journal:  Front Pharmacol       Date:  2018-02-15       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.